Price T Rowe Associates Inc Ideaya Biosciences, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,052,500 shares of IDYA stock, worth $137 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,052,500
Previous 3,566,278
13.63%
Holding current value
$137 Million
Previous $127 Million
40.14%
% of portfolio
0.02%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding IDYA
# of Institutions
206Shares Held
71.2MCall Options Held
29.8KPut Options Held
8.5K-
Black Rock Inc. New York, NY5.97MShares$201 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.86MShares$164 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.16MShares$140 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.81MShares$128 Million0.09% of portfolio
-
State Street Corp Boston, MA3.16MShares$107 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.62B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...